{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:27:06Z","timestamp":1769732826358,"version":"3.49.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.clbc.2023.11.001","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T04:44:21Z","timestamp":1699418661000},"page":"122-130.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatments and Prognosis of the Breast Ductal Carcinoma In Situ"],"prefix":"10.1016","volume":"24","author":[{"given":"Yaxue","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingsheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1319-8912","authenticated-orcid":false,"given":"Fengyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clbc.2023.11.001_bib0001","first-page":"563","article-title":"Ductal carcinoma in situ of breast: update","volume":"51","author":"Badve","year":"2019","journal-title":"Pathology (Phila)"},{"issue":"4","key":"10.1016\/j.clbc.2023.11.001_bib0002","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejso.2021.10.030","article-title":"Advances and controversies in management of breast ductal carcinoma in situ (DCIS)","volume":"48","author":"Farante","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.11.001_bib0003","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.001_bib0004","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2023.11.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9605439","article-title":"Global increase in breast cancer incidence: risk factors and preventive measures","volume":"2022","author":"Kashyap","year":"2022","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.001_bib0006","doi-asserted-by":"crossref","first-page":"E42","DOI":"10.1148\/radiol.229011","article-title":"US, mammography, and histopathologic evaluation to identify low nuclear grade ductal carcinoma in situ","volume":"303","author":"Lee","year":"2022","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clbc.2023.11.001_bib0007","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s12282-021-01225-0","article-title":"Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study","volume":"28","author":"Tanaka","year":"2021","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.clbc.2023.11.001_bib0008","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.001_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.canrad.2013.01.011","article-title":"Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases","volume":"17","author":"Cutuli","year":"2013","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.clbc.2023.11.001_bib0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","article-title":"NCCN Guidelines\u00ae insights: breast cancer, version 4.2021","volume":"19","author":"Gradishar","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.clbc.2023.11.001_bib0011","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1245\/s10434-017-6018-9","article-title":"Surgical upstaging rates for vacuum assisted biopsy proven DCIS: implications for active surveillance trials","volume":"24","author":"Grimm","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.001_bib0012","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SLA.0b013e3182263bb0","article-title":"Institutional variation in the surgical treatment of breast cancer: a study of the NCCN","volume":"254","author":"Greenberg","year":"2011","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.clbc.2023.11.001_bib0013","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","article-title":"Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ","volume":"27","author":"Tuttle","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.11.001_bib0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev-med-050715-104920","article-title":"Controversies in the treatment of ductal carcinoma in situ","volume":"68","author":"Barrio","year":"2017","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.001_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-013-2455-8","article-title":"Can we select individuals with low-risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis","volume":"138","author":"Rakovitch","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.001_bib0016","first-page":"169","article-title":"Guideline for HER2 detection in breast cancer, the 2019 version","volume":"48","year":"2019","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.001_bib0017","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000328054","article-title":"St. Gallen 2011: summary of the consensus discussion","volume":"6","author":"Gnant","year":"2011","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.clbc.2023.11.001_bib0018","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-015-1904-7","article-title":"Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis","volume":"15","author":"Stuart","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2023.11.001_bib0019","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/cncr.11580","article-title":"Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial","volume":"98","author":"Poggi","year":"2003","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.clbc.2023.11.001_bib0020","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.001_bib0021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12893-017-0210-5","article-title":"DCIS and axillary nodal evaluation: compliance with national guidelines","volume":"17","author":"Mitchell","year":"2017","journal-title":"BMC Surg"},{"key":"10.1016\/j.clbc.2023.11.001_bib0022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane Project","volume":"101","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.001_bib0023","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/j.clbc.2019.08.002","article-title":"Ductal carcinoma in situ: a French National Survey. Analysis of 2125 Patients","volume":"20","author":"Cutuli","year":"2020","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2023.11.001_bib0024","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1245\/s10434-014-4334-x","article-title":"Growing use of mastectomy for ductal carcinoma-in situ of the breast among young women in the United States","volume":"22","author":"Rutter","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.001_bib0025","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2015.01.054","article-title":"Early postoperative outcomes in lumpectomy versus simple mastectomy","volume":"198","author":"Chatterjee","year":"2015","journal-title":"J Surg Res"},{"issue":"7","key":"10.1016\/j.clbc.2023.11.001_bib0026","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/annonc\/mdg289","article-title":"Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients","volume":"14","author":"H\u00e4rtl","year":"2003","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.001_bib0027","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1245\/s10434-019-07548-9","article-title":"A comparison of patient-reported outcomes after breast-conserving surgery and mastectomy with implant breast reconstruction","volume":"26","author":"Flanagan","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.001_bib0028","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2023.11.001_bib0029","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.breast.2021.11.018","article-title":"De-escalating axillary surgery in early-stage breast cancer","volume":"62","author":"Hersh","year":"2022","journal-title":"Breast"},{"issue":"9","key":"10.1016\/j.clbc.2023.11.001_bib0030","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1245\/s10434-020-08374-0","article-title":"Analysis of surgical trends for axillary lymph node management in patients with ductal carcinoma in situ using the NSQIP database: are we following national guidelines?","volume":"27","author":"Pyfer","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2023.11.001_bib0031","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1200\/JCO.20.00459","article-title":"Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial","volume":"38","author":"Naoum","year":"2020","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.clbc.2023.11.001_bib0032","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1200\/JCO.19.02896","article-title":"Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment","volume":"38","author":"McLaughlin","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.11.001_bib0033","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2023.11.001_bib0034","doi-asserted-by":"crossref","first-page":"379","DOI":"10.21037\/gs.2017.11.04","article-title":"Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments","volume":"7","author":"Gillespie","year":"2012","journal-title":"Gland Surg"},{"key":"10.1016\/j.clbc.2023.11.001_bib0035","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/PRS.0b013e31826d0faa","article-title":"Reduced incidence of breast cancer-related lymphedema following mastectomy and breast reconstruction versus mastectomy alone","volume":"130","author":"Card","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.clbc.2023.11.001_bib0036","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/SLA.0000000000001128","article-title":"Immediate implant reconstruction is associated with a reduced risk of lymphedema compared to mastectomy alone: a prospective cohort study","volume":"263","author":"Miller","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.clbc.2023.11.001_bib0037","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.breast.2015.04.008","article-title":"The changing role of axillary treatment in breast cancer: who will remain at risk for developing arm morbidity in the future?","volume":"24","author":"Lopez Penha","year":"2015","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2023.11.001_bib0038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","article-title":"Risk factors for lymphoedema in women with breast cancer: a large prospective cohort","volume":"28","author":"Kilbreath","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2023.11.001_bib0039","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","article-title":"A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy","volume":"86","author":"Kim","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.clbc.2023.11.001_bib0040","doi-asserted-by":"crossref","first-page":"476e8","DOI":"10.1016\/j.ejca.2009.12.004","article-title":"No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN)","volume":"46","author":"Farante","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2023.11.001_bib0041","doi-asserted-by":"crossref","first-page":"96e102","DOI":"10.1002\/bjs.11377","article-title":"Multicentre study of the risk of invasive cancer and use of sentinel node biopsy in women with a preoperative diagnosis of ductal carcinoma in situ","volume":"107","author":"Munck","year":"2020","journal-title":"Br J Surg"},{"issue":"41","key":"10.1016\/j.clbc.2023.11.001_bib0042","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"32","key":"10.1016\/j.clbc.2023.11.001_bib0043","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","volume":"31","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.clbc.2023.11.001_bib0044","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS","volume":"32","author":"W\u00e4rnberg","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.001_bib0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.clbc.2023.11.001_bib0046","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9169","key":"10.1016\/j.clbc.2023.11.001_bib0047","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clbc.2023.11.001_bib0048","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2011.02.005","article-title":"Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials","volume":"100","author":"Petrelli","year":"2011","journal-title":"Radiother Onco."},{"issue":"1","key":"10.1016\/j.clbc.2023.11.001_bib0049","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12253-018-0553-y","article-title":"Endocrine therapy for ductal carcinoma in situ (DCIS) of the breast with breast conserving surgery (BCS) and radiotherapy (RT): a meta-analysis","volume":"26","author":"Yan","year":"2020","journal-title":"Pathol Oncol Res"},{"issue":"10218","key":"10.1016\/j.clbc.2023.11.001_bib0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","article-title":"Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial","volume":"395","author":"Cuzick","year":"2020","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.clbc.2023.11.001_bib0051","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/cncr.34155","article-title":"De-escalation of five-year adjuvant endocrine therapy in patients with estrogen receptor-low positive (immunohistochemistry staining 1%-10%) breast cancer: propensity-matched analysis from a prospectively maintained cohort","volume":"128","author":"Cai","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.11.001_bib0052","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10549-021-06488-x","article-title":"Long-term outcomes of women with large DCIS lesions treated with breast-conserving therapy","volume":"192","author":"Rodin","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"21","key":"10.1016\/j.clbc.2023.11.001_bib0053","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"Bijker","year":"2006","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.clbc.2023.11.001_bib0054","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/1078-0432.CCR-21-1239","article-title":"Prognostic and predictive value of HER2 expression in ductal carcinoma in situ: results from the UK\/ANZ DCIS randomized trial","volume":"27","author":"Thorat","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.clbc.2023.11.001_bib0055","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-20-4635","article-title":"Prognostic value of ER and PgR expression and the impact of multi-clonal expression for recurrence in ductal carcinoma in situ: results from the UK\/ANZ DCIS trial","volume":"27","author":"Thorat","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2023.11.001_bib0056","article-title":"Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis","volume":"378","author":"Bundred","year":"2022","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.clbc.2023.11.001_bib0057","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/cncr.31221","article-title":"Margins in breast cancer: how much is enough?","volume":"124","author":"Pilewskie","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2023.11.001_bib0058","article-title":"Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study","volume":"383","author":"Schmitz","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2023.11.001_bib0059","doi-asserted-by":"crossref","first-page":"m1570","DOI":"10.1136\/bmj.m1570","article-title":"Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study","volume":"369","author":"Mannu","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2023.11.001_bib0060","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.amjsurg.2005.06.005","article-title":"Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins","volume":"190","author":"MacDonald","year":"2005","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2023.11.001_bib0061","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.2008.17.5182","article-title":"Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ","volume":"27","author":"Dunne","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.11.001_bib0062","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of Surgical Oncology-American Society for Radiation Oncology-American Society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ","volume":"34","author":"Morrow","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923002732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923002732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:26:08Z","timestamp":1761513968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923002732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1526820923002732"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.11.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatments and Prognosis of the Breast Ductal Carcinoma In Situ","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}